אוקו שלי בע"מ

Ukko is creating a comprehensive, clinically validated map of the molecular structure of food allergies, revealing critical information about the biological mechanisms that govern human-food interactions. The company uses the platform to create new versions of proteins that do not elicit an immune response, based on this map. These proteins enable a completely new approach to treating protein-based allergies.

Patients with food allergies, Food manufacturers, physicians.

Uri Lopatin - CEO

Moshe Ben-David - CTO